Cargando…
Does Timing of Receipt of Appropriate Antimicrobial Therapy Make a Difference Among Patients With Serious Infections Due to Resistant Gram-Negative Pathogens?
Autores principales: | Berger, Ariel, Bhagnani, Tarun, Wang, Rosa, Zhao, Qi, Ye, Michael, Lodise, Thomas P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6597026/ http://dx.doi.org/10.1093/ofid/ofw194.154 |
Ejemplares similares
-
Associations Between Timeliness of Therapy and Clinical and Economic Outcomes Among Patients With Serious Infections Due to Gram-negative Bacteria (GNB): How Much Does Delayed Appropriate Therapy (DAT) Matter?
por: Bonine, Nicole G, et al.
Publicado: (2017) -
Antimicrobial Resistance or Delayed Appropriate Therapy—Does One Influence Outcomes More Than the Other Among Patients With Serious Infections Due to Carbapenem-Resistant Versus Carbapenem-Susceptible Enterobacteriaceae?
por: Lodise, Thomas P, et al.
Publicado: (2019) -
Carbapenem-resistant Enterobacteriaceae (CRE) or Delayed Appropriate Therapy (DAT)—Does One Affect Outcomes More Than the Other Among Patients With Serious Infections Due to Enterobacteriaceae?
por: Lodise, Thomas, et al.
Publicado: (2017) -
Role of Respiratory Virus Panels in Antimicrobial Stewardship in Immunocompromised Patients
por: Mercuro, Nicholas, et al.
Publicado: (2016) -
Laboratory-Confirmed Human Coronavirus Infections Among Children: Does Type Matter?
por: Sanderson, Susan K., et al.
Publicado: (2016)